Russell Investments Group
FHTX icon

Russell Investments Group’s Foghorn Therapeutics FHTX Stock Holding History

Russell Investments Group’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.4K Buy
14,429
+11,531
+398% +$51.2K ﹤0.01% 3536
2026
Q1 		$13.9K Sell
2,898
-3,040
-51% -$16.7K ﹤0.01% 3709
2025
Q4 		$32.1K Buy
5,938
+396
+7% +$1.79K ﹤0.01% 3467
2025
Q3 		$27.1K Buy
5,542
+5,502
+13,755% +$29.2K ﹤0.01% 3505
2025
Q2 		$188 Sell
40
-1,331
-97% -$5.56K ﹤0.01% 3791
2025
Q1 		$5K Sell
1,371
-106
-7% -$483 ﹤0.01% 3361
2024
Q4 		$6.97K Hold
1,477
– – ﹤0.01% 3215
2024
Q3 		$13.8K Buy
+1,477
New +$10.7K ﹤0.01% 3029
2024
Q1 		– Sell
-100
Closed -$645 – 3328
2023
Q4 		$645 Buy
+100
New +$431 ﹤0.01% 3099
2023
Q2 		– Sell
-30,017
Closed -$186K – 3475
2023
Q1 		$186K Buy
+30,017
New +$196K ﹤0.01% 2488

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Russell Investments Group's FHTX Position: Q2 2026 in Review

Russell Investments Group increased its Foghorn Therapeutics (FHTX) stake by 398% in Q2 2026, buying an estimated $51.2K and bringing the position to 14,429 shares worth $70.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3536.

Russell Investments Group first reported a position in FHTX in Q1 2023 and has held it in 10 quarters since. The position peaked at $186K in Q1 2023. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Russell Investments Group held 14,429 shares of Foghorn Therapeutics worth $70.4K as of Q2 2026.
  • Russell Investments Group bought 11,531 Foghorn Therapeutics shares in Q2 2026, an estimated $51.2K.
  • Foghorn Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3536 holding.
  • Russell Investments Group first reported a position in Foghorn Therapeutics in Q1 2023 and has held it in 10 quarters since.
  • Russell Investments Group's Foghorn Therapeutics position peaked at $186K in Q1 2023.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.